key: cord-0683859-d4plesxb
authors: Thylefors, Josefine; Thuresson, Sara; Alsved, Malin; Widell, Anders; Fraenkel, Carl-Johan; Löndahl, Jakob; Medstrand, Patrik; Senneby, Erik
title: Detection of SARS-CoV-2 RNA on surfaces in a COVID-19 hospital ward indicates airborne viral spread
date: 2022-03-11
journal: J Hosp Infect
DOI: 10.1016/j.jhin.2022.02.025
sha: 1ae5cd7d3934badb94a41130496c19e30916c115
doc_id: 683859
cord_uid: d4plesxb

nan

Most respiratory viruses, including coronaviruses, are conventionally associated with mainly droplet and contact transmission. This has affected recommendations regarding infection prevention precautions for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1] . However, it is now demonstrated that SARS-CoV-2 can be detected in air samples in hospital environments [2] , and that the airborne route plays a role in the transmission [3] [4] . Virus particles transported in air will most likely be deposited on surfaces and viable SARS-CoV-2 have been detected for up to 72 hours on surfaces in experimental settings [5] . In this this study we investigated the distribution of SARS-CoV-2 RNA on surfaces in a COVID-19 hospital ward through swabbing surfaces as an indicator for airborne transfer of SARS-CoV-2. We also investigated whether the detection rate of SARS-CoV-2 RNA was impacted after terminal cleaning of the ward. The samples were collected from a medical ward with 17 patient rooms in a tertiary care hospital in Sweden (Skåne University Hospital), which had been designated as a COVID-19 ward four weeks earlier. The patient rooms had a negative pressure (-1 to -4 Pa) with approximately 2.7 air changes per hour. Staff and storage rooms had a positive pressure (+2 to +4 Pa). At sampling on day 1, in January 2021, there were 17 patients in the ward (one room was empty and there were two patients in one room). Most patients received supplemental oxygen or oxygen through high flow nasal cannula (HFNC). Movable highefficiency particulate air (HEPA) filters had been placed in six rooms, where patients were treated with HFNC. At the time of sampling, there were no known COVID-19 cases among the health care workers. The last known case of SARS-CoV-2 positive staff was 15 days prior to sampling. Swabbing of 75 surfaces was performed on day 1. Later that day, patients with ongoing isolation precautions were transferred to other locations. The terminal cleaning of the ward included alcohol-based disinfectant on surfaces (Liv DES +72 % ethanol, Clemondo, or DAX isopropanol 45 %, Kiiltoclean, Sweden), and an oxidizing compound on floors (Virkon Rely-On 1 %, Viroderm, Sweden). Subsequently, non-COVID-19 patients were admitted to the ward. On day 2, samples were collected from the same 75 surfaces on adjacent areas. The surfaces were divided into three categories: low (on the floor or a surface <10 cm above), medium-high (approximately 1 meter above the floor) and high (> 1.4 meters above the floor). Surfaces were sampled with flocked swabs (SRK 906 C Copan, Brescia, Italy) and samples were stored in -80 o C until analysis. The areas of the sampled surfaces, which were made of plastic, painted wood or metal, ranged from approximately 20 to 50 cm 2 . RNA was extracted using the MagNA Pure 96 DNA and Viral NA Small Volume Kit (Roche Molecular Systems, Inc.) in a MagNA Pure 96 system (Roche Diagnostics Scandinavia AB). Reverse transcription quantitative polymerase chain reaction was performed as described by Thuresson et al. [6] . All samples were run in duplicates, and samples were considered positive if one of the duplicates had a cycle threshold (Ct) value <40. In total, 43 of 150 samples (29%) were positive for SARS-CoV-2 RNA (Table 1) . Of the positive samples, 25 (58 %) were from high surfaces and 16 (37 %) were from low surfaces. Eleven patient rooms (69%) had at least one positive surface. SARS-CoV-2 RNA could be detected in four of the six rooms where portable HEPA filters had been placed and in seven of the ten rooms without HEPA filters. The mean Ct value for all positive samples was 39 (range 33-40). It is likely that viral RNA found on high surfaces were deposited through an airborne route, since these surfaces are not contact surfaces or exposed to large droplets. Other routes of transportation (droplets or direct contact) could also be involved in the spread of virus to medium-high and low surfaces. Many surfaces were positive after cleaning on day 2. There might be several reasons for this. Firstly, not all surfaces that were sampled were routinely cleaned. Secondly, surfaces that were disinfected properly may still have levels of detectable SARS-CoV-2 RNA left on them (and not RNA from viable viruses). Another possibility is deposition of SARS-CoV-2 to surfaces from unknown COVID-19 cases. The presence of a HEPA filter in a patient room did not seem to reduce the chance of detecting SARS-CoV-2 RNA on surfaces. Our findings support that airborne spread is a transmission route for COVID-19. Also, though the infection control implications are uncertain, our results suggest that cleaning may not be sufficient to eradicate SARS-CoV-2 RNA from the environment. 

WHO Infection Prevention and Control Research and Development Expert Group for COVID-19. Use of medical face masks versus particulate respirators as a component of personal protective equipment for health care workers in the context of the COVID-19 pandemic

A review on measurements of SARS-CoV-2 genetic material in air in outdoor and indoor environments: Implication for airborne transmission

Dismantling myths on the airborne transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

World Health Organization. Mask use in the context of COVID-19

Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1. medRxiv [Preprint

Airborne SARS-CoV-2 in hospitals -effects of aerosol-generating procedures, HEPAfiltration units, patient viral load and physical distance

We acknowledge Sviataslau Sasinovich and Jonathan Soldemyr for important help.

The study was supported by grants from AFA insurance (grant numbers 200109 and 200255), the Swedish Research Council FORMAS (grant number 2020-01490), the SciLifeLab National COVID-19 Research Program, the Knut and Alice Wallenberg Foundation, the Swedish Research Council (grant number 2020-02344) and Österlund Foundation. The funders had no role in design of the study or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.